CHGCF Financials
Chugai Pharmaceutical Co. Ltd - Financial statements & key metrics
Stock Price
$60.19
Market Cap
$99.06B
P/E Ratio
36.0
EPS
$1.67
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$1.26T
Gross Profit
$895.03B
Operating Income
$590.71B
Net Income
$434.39B
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$2.47T
Total Liabilities
$443.25B
Shareholders Equity
$2.03T
Cash & Equivalents
$426.97B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$389.79B
CapEx
$76.34B
Free Cash Flow
$313.45B
Profitability Metrics
Gross Margin
71.1%
Operating Margin
0.5%
Net Margin
0.3%
ROE
0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CHGCF revenue?
CHGCF's most recent quarterly revenue was $1.26T. Annual revenue can be calculated by summing the four most recent quarters.
Is CHGCF profitable?
CHGCF reported a profit of $434.39B in the most recent quarter. The net profit margin is 0.3%.
What is CHGCF market cap?
CHGCF has a market capitalization of $99.06B, making it a large-cap stock.
Does CHGCF have debt?
View CHGCF's balance sheet for debt information.
What is CHGCF cash flow?
CHGCF's most recent quarterly free cash flow was $313.45B.